Krajícková J, Pesáková V, Adam M, Senius K E
Arzneimittelforschung. 1987 Feb;37(2):177-80.
Tolfenamic acid (Clotam) has been used in the therapy of rheumatic diseases for some years. Regarding its chemical structure it belongs to the group of fenamates. The effect of tolfenamic acid on the synthesis of collagen and proteoglycans in granulation tissue, skin or cartilage of rat weanlings was tested and compared with the action of mefenamic acid. According to the results obtained, tolfenamic acid is a potent inhibitor of collagen as well as proteoglycan syntheses. The concentrations of the constituents of proteoglycans, i.e. protein core, link protein as well as glycosaminoglycans were decreased in the tissue after treatment with tolfenamic acid. In comparison with mefenamic acid, if the same doses were used (50 mg and 100 mg/kg of body weight/day in in vivo experiments and 10 mg/g wet tissue in in vitro experiments), tolfenamic acid exhibits more distinct inhibitory effect. A general inhibitory effect of tolfenamic acid on proteosynthesis is suggested.
托芬那酸(Clotam)已用于治疗风湿性疾病数年。就其化学结构而言,它属于芬那酸盐类。测试了托芬那酸对大鼠断奶幼崽肉芽组织、皮肤或软骨中胶原蛋白和蛋白聚糖合成的影响,并与甲芬那酸的作用进行了比较。根据所得结果,托芬那酸是胶原蛋白和蛋白聚糖合成的有效抑制剂。用托芬那酸处理后,组织中蛋白聚糖的成分,即蛋白核心、连接蛋白以及糖胺聚糖的浓度降低。与甲芬那酸相比,若使用相同剂量(体内实验中为50毫克和100毫克/千克体重/天,体外实验中为10毫克/克湿组织),托芬那酸表现出更明显的抑制作用。提示托芬那酸对蛋白质合成具有普遍抑制作用。